May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Neuropeptides in Allergy
Author Affiliations & Notes
  • A. Micera
    CIR, Laboratory of Ophthalmology, University Campus BioMedico, Rome, Italy
    IRCCS- GB Bietti Eye Foundation, Rome, Italy
  • S. Aronni
    CIR, Laboratory of Ophthalmology, University Campus BioMedico, Rome, Italy
  • B. Stampachiacchiere
    CIR, Laboratory of Ophthalmology, University Campus BioMedico, Rome, Italy
    IRCCS- GB Bietti Eye Foundation, Rome, Italy
  • L. Mastrella
    CIR, Laboratory of Ophthalmology, University Campus BioMedico, Rome, Italy
  • A. Lambiase
    CIR, Laboratory of Ophthalmology, University Campus BioMedico, Rome, Italy
  • S. Bonini
    CIR, Laboratory of Ophthalmology, University Campus BioMedico, Rome, Italy
  • Footnotes
    Commercial Relationships  A. Micera, None; S. Aronni, None; B. Stampachiacchiere, None; L. Mastrella, None; A. Lambiase, None; S. Bonini, None.
  • Footnotes
    Support  IRCCS - G.B. Bietti Eye Foundation, Rome, Italy
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 6049. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Micera, S. Aronni, B. Stampachiacchiere, L. Mastrella, A. Lambiase, S. Bonini; Neuropeptides in Allergy. Invest. Ophthalmol. Vis. Sci. 2008;49(13):6049. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To investigate the tear levels of neuropeptides such as Substance P (SP), Vasointestinal Peptide (VIP), Calcitonin Gene-Related Peptide (CGRP) and Neuropeptide Y (NPY), at baseline and after allergen Conjunctival Provocation Test (CPT) in patients with allergic conjunctivitis and healthy subjects.

Methods: : Eight patients (M, 28.90±2.00 yrs) with evidence of skin sensitivity but without ocular symptoms have been evaluated before and after CPT. Four healthy age-matched subjects (M, 29.00±0.00 yrs) were used as controls. CPT was performed with increasing concentration of specific allergen in the right eye (RE) till grade +2 of hyperemia was obtained. Balanced saline solution (BSS) was used to challenge for the controlateral eye (LE). Tears (30-50µL) were collected both at baseline and within 15min from last allergen/BSS challenge. A commercially available EIA test was used to quantify neuropeptides in normalized samples (A280-spectrophotometer analysis).

Results: : At baseline, the tear levels of neuropeptides were not significantly different between allergic and controls (p>.05). A significant increase in tear levels of SP (p<.01), CGRP (p<.001), VIP (p<.001) and NPY (p<.001) was observed in allergic patients following challenge, when compared to baseline, unchallenged controlateral and controls. The levels of neuropeptides did not change significantly when CPT was performed in controls (p>.05).

Conclusions: : Specific CPT resulted in an increase of all neuromediators in the tears from allergic patients while no increase was observed in control healthy subjects or in both groups upon saline stimulation. These finding suggest that neuromediator increase (neurogenic inflammation) is strengthen linked to the specific allergic stimulation.

Keywords: conjunctiva • neuropeptides • immunomodulation/immunoregulation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×